AUSTRALIAN and New York listed medical devices company ResMed has completed its $225m acquisition of US digital therapeutics company Propeller Health.
The company's focus includes support for COPD and other chronic diseases with the aim of keeping patients out of hospitals, reducing the overall cost of healthcare.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Jan 19